Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06117839
Other study ID # ahmedsallam
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 1, 2023
Est. completion date January 1, 2025

Study information

Verified date November 2023
Source Assiut University
Contact Ahmed Sallam Abo El-azaiem, bachelor's
Phone 01005732964
Email ahmedsallam2020159@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Our study will be a prospective study To compare between the rate of infection after using antibiotic loaded cement and regular cement after total knee arthroplasty in primary knee osteoarthritis.this will be at assiut university trauma hospital .There are 2 groups ,first group is patients will be treated with regular bone cement ,the second one is patient will be treated with antibiotic loaded bone cement, commonly used antibiotics includeGentamycin powder.


Description:

Total Joint arthroplasty (TJA) is among the major and most successful orthopedic surgeries . It is indicated when there is impaired joint function that requires prosthesis replacement .Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are the most replaced joints . TKA is becoming more common over the world, with 5 million degenerative knee joint replacement procedures projected by 2030 . Although perioperative antimicrobial procedures have improved significantly, periprosthetic joint infection (PJI) following TKA remains a serious complication for patients and a significant burden on the healthcare system . PJI is a leading cause of TKA revision surgery, accounting for more than 15% of all revisions.that can cause a long hospital stay, increase the risk of readmission, and lead to poor patient outcomes, such as decreased function and a lower quality of life. In the worst case, PJI can lead to amputation or even death . Antibiotic-loaded bone cement (ALBC) has been recommended to reduce the risk of PJI. The aim of such a strategy is to promptly release antibiotics at the action site with very little systemic exposure, which may not be achieved by systemic antibiotics due to insufficient blood supply (1) but in the literature, it is uncertain whether ALBC or plain bone cement (PBC) should be used in PTKA. ALBC has been shown to decrease significant complications, although it has the disadvantage of diminishing cement strength. A meta-analysis published in 2015 discovered no statistically significant difference in the incidence of PJI in patients receiving two cement materials during PTKA , another meta-analysis was done in 2022 demonstrated that the preventive application of ALBC during PTKA could reduce the rates of deep PJI, However, the existing related articles are mostly single-center and retrospective studies, and further high-quality ones are needed for confirmation ,so we will conduct our study to compare between ALBC and PBC in TKA infection.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 42
Est. completion date January 1, 2025
Est. primary completion date December 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient with primary knee osteoarthritis. - Patient underwent total knee arthroplasty. Exclusion Criteria: - Patient with rheumatoid knee osteoarthritis. - Patient with post-traumatic knee osteoarthritis. - Patient with knee tumor. - Patient has allergy to antibiotics used in the study. - Patient with any operative procedure in the knee.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
using antibiotic loaded cement and regular cement after total knee arthroplasty in primary knee osteoarthritis.
-There are 2 groups ,first group is patients will betreated with regular bone cement ,the second one is patient will be treated with antibiotic loaded bone cement, commonly used antibiotics include Gentamycin powder .

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Infection eradication rate patients will be evaluated clinically and undergo lab evaluation (CRP and CBC).Patients will be routinely monitored for clinical signs of infection, including cellulitis or draining sinuses. Radiographs will be obtained at 2,6 and 12 months.
Laboratory tests as CRPwill be used to assess the infection.
A negative CRP indicate clean field and eradication of infection.
12 months postoperative
Secondary Cost/benefit ratio. study the cost in egyptian pound 12 months postoperative
See also
  Status Clinical Trial Phase
Recruiting NCT03302013 - All Ligaments Left In Knee Arthroplasty Trial N/A
Completed NCT01364870 - Effect of TENS for Pain and Function After Total Knee Replacement N/A
Completed NCT01850394 - Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement N/A
Completed NCT04998825 - Efficacy and Tolerability of Proteoglycan F in the Treatment of Knee Osteoarthritis N/A
Completed NCT03232957 - Intrathecal Morphine for Unilateral Total Knee Arthroplasty N/A
Recruiting NCT05509972 - In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Recruiting NCT03523897 - A Prospective Study to Evaluate Robot Assisted Total Knee Replacement Outcomes N/A